Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Am J Ind Med. 2019 Jun 20;62(8):672–679. doi: 10.1002/ajim.23015

Table III.

Association between exposure control use during administration of antineoplastic drugs and fecundity among women attempting pregnancy (n=2,649).

n (%) Median Pregnancy Attempt in Months [IQR] Unadjusted TR (95%CI) Adjusted TR* (95%CI)
Antineoplastic drug administration
Never 1572 (59.3) 3[1,7] 1(REF) - 1(REF) -
Yes, prior to baseline 786 (29.7) 3[1,9] 1.08 0.98–1.18 1.02 0.93–1.12
Yes, at baseline
 Exposure controls not always used 21 (0.79) 4 [2,11] 1.33 0.83–2.15 1.25 0.79–1.96
 Exposure controls always used 270 (10.2) 3[1,8] 1.00 0.87–1.15 0.96 0.83–1.10
*

Adjusted for age, race, BMI, smoking status, marital status, hours worked per week, frequency of occupational moving or lifting a heavy load, and current exposure to ionizing radiation, high-level disinfectants, anesthetic gases, and aerosolized drugs.

Abbreviations: n, number of nurses; IQR, inter-quartile range; TR, time ratio; REF, reference.